Publicacions en què col·labora amb Josefina Galende del Canto (27)

2017

  1. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy*

    Leukemia and Lymphoma, Vol. 58, Núm. 5, pp. 1144-1152

2015

  1. The cellular origin and malignant transformation of Waldenström macroglobulinemia

    Blood, Vol. 125, Núm. 15, pp. 2370-2380

2014

  1. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: New criteria for differential diagnosis and risk stratification

    Leukemia, Vol. 28, Núm. 1, pp. 166-173

2010

  1. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: Comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells

    British Journal of Haematology, Vol. 148, Núm. 1, pp. 110-114

2009

  1. Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease

    International Journal of Cancer, Vol. 124, Núm. 2, pp. 367-375

  2. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients

    Blood, Vol. 114, Núm. 20, pp. 4369-4372

2008

  1. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

    Blood, Vol. 112, Núm. 10, pp. 4017-4023

  2. Peripheral blood dendritic cell subsets from patients with monoclonal gammopathies show an abnormal distribution and are functionally impaired

    Oncologist, Vol. 13, Núm. 1, pp. 82-92

2007

  1. Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia

    Clinical Lymphoma and Myeloma, Vol. 7, Núm. 9, pp. 573-579

  2. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

    Blood, Vol. 110, Núm. 7, pp. 2586-2592

2006

  1. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vβ repertoire

    Cancer, Vol. 106, Núm. 6, pp. 1296-1305

2005

  1. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment

    Leukemia, Vol. 19, Núm. 3, pp. 449-455

2004

  1. Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias

    Journal of Biological Regulators and Homeostatic Agents, Vol. 18, Núm. 2, pp. 161-165

  2. Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients

    International Journal of Cancer, Vol. 112, Núm. 5, pp. 884-889

1999

  1. In vitro growth in acute myeloblastic leukemia: Clinico-biological correlations

    Leukemia and Lymphoma, Vol. 36, Núm. 1-2, pp. 1-7

1998

  1. In vitro growth in acute myeloblastic leukaemia: Relationship with other clinico-biological characteristics of the disease

    British Journal of Haematology, Vol. 103, Núm. 1, pp. 137-142

1997

  1. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis

    Leukemia Research, Vol. 21, Núm. 7, pp. 651-656

  2. Rhabdomyolysis associated with septicemia after autologous bone marrow transplantation [1]

    Bone Marrow Transplantation

1996

  1. ACCION DE ALGUNOS FACTORES DE CRECIMIENTO HEMATOPOYETICOS SOBRE LOS BLASTOS DE LEUCEMIA AGUDA MIELOBLASTICA

    Sangre, Vol. 41, Núm. 1, pp. 3-8

  2. Responsiveness of AML cells to recombinant hematopoietic growth factors: relationship with morphological and immunological characteristics of blast cells.

    Leukemia research